Gastroenteropancreatic Neuroendocrine Tumor Disease
2 clinical trials · Condition
◉ Watch Gastroenteropancreatic Neuroendocrine Tumor Disease
| Record | Firm | Date |
|---|---|---|
| Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy (NCT05477576) | RayzeBio, Inc. | 2022-03-24 |
Track Gastroenteropancreatic Neuroendocrine Tumor Disease automatically
Every clearance here is in the API, with alerts when new ones post.